MAPT and Alzheimer disease: The proteolytic cleavage of DYRK1A by calpain 1 gives a truncated form with a higher kinase activity towards Tau phosphorylation, this cleavage being positively correlated with the 3R-Tau/4R-Tau ratio in the brains of AD patients [26].